Summary

Europe Cardiac Rhythm Management Devices Market is valued approximately at USD XX million in 2023 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2024-2032. Cardiac rhythm management (CRM) devices are sophisticated medical tools designed for monitoring and regulating the electrical functions of the heart. They are specifically employed in individuals experiencing heart rhythm irregularities such as arrhythmias, bradycardia (slow heart rate), and tachycardia (fast heart rate). These devices encompass implanted cardioverter defibrillators (ICDs), which address life-threatening arrhythmias, pacemakers that sustain a steady heart rhythm by delivering electrical impulses, and cardiac resynchronization therapy (CRT) devices that enhance the performance of heart failure patients' hearts. These devices are essential for improving patients' quality of life and controlling cardiac diseases. The increasing focus on remote patient monitoring and telemedicine solutions is a key trend that is supporting the growth of the Europe Cardiac Rhythm Management Devices Market.

The surge in the incidences of the cardiovascular diseases is directly associated with the demand of the cardiac rhythm management devices. For instance, the British Heart Foundation's Report titled 'UK Factsheet' published in July 2021, reports that 7.6 million people in the United Kingdom live with heart and circulatory diseases. In Europe, healthcare providers are increasingly using remote monitoring technologies for cardiac devices such as pacemakers, ICDs, and CRT devices due to rising cardiovascular disease rates. Advancement in connectivity and data analytics allow for proactive monitoring of heart rhythms, early detection of issues and improved patient outcomes, along with cutting down healthcare costs. Moreover, modern pacemakers often incorporate advanced monitoring capabilities. They can capture and save data regarding the patient's heart rhythm and pacing patterns, enabling healthcare professionals to monitor the patient's cardiac status closely and make informed modifications to their treatment regimen. Consequently, the array of benefits offered by these devices is expected to bolster market revenue over the forecast period. However, stringent regulatory approvals, along with side effects of therapeutic radiation on implantable cardiac rhythm devices is expected to hinder the Europe Cardiac Rhythm Management Devices market growth between 2022 and 2032.

The key countries considered for the Europe Cardiac Rhythm Management Devices Market study includes UK, Germany, France, Italy, Spain, and Rest of Europe. In 2023, Germany was the dominating market with the highest number of market shares because the region has a significant burden of cardiovascular diseases, along with German healthcare systems are increasingly adopting data-driven approaches. This influences the demand for CRM devices with demonstrably positive clinical outcomes and cost-effectiveness data. Also, the growing focus on advanced technologies and patient well-being, and a favorable regulatory and reimbursement environment are further contributing to the regional market expansion at a substantial rate. The market in UK, on the other hand, is expected to grow at the fastest rate over the forecast period.

Major market player included in this report are:
BIOTRONIK SE & Co. KG
Schiller AG
Medtronic PLC
Koninklijke Philips N.V.
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10

The detailed segments and sub-segment of the market are explained below:

By Product
Pacemakers
Defibrillators
Cardiac Resynchronization Therapy (CRT))

By Region:
Europe
UK
Germany
France
Spain
Italy
ROE

Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032

Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and Country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

ページTOPに戻る

Table of Contents

Chapter 1. Europe Cardiac Rhythm Management Devices Market Definition and Research Assumptions
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates

Chapter 2. Executive Summary
2.1. Europe Cardiac Rhythm Management Devices Market Size & Forecast (2022- 2032)
2.2. Regional Summary
2.3. Segmental Summary
2.3.1. By Product
2.4. Key Trends
2.5. Recession Impact
2.6. Analyst Recommendation & Conclusion
Chapter 3. Europe Cardiac Rhythm Management Devices Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
Chapter 4. Europe Cardiac Rhythm Management Devices Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Europe Cardiac Rhythm Management Devices Market Size & Forecasts by Product 2022-2032
5.1. Pacemakers
5.2. Defibrillators
5.3. Cardiac Resynchronization Therapy (CRT))
Chapter 6. Europe Cardiac Rhythm Management Devices Market Size & Forecasts by Country 2022-2032
6.1. U.K. Cardiac Rhythm Management Devices Market
6.1.1. Product breakdown size & forecasts, 2022-2032
6.2. Germany Cardiac Rhythm Management Devices Market
6.3. France Cardiac Rhythm Management Devices Market
6.4. Spain Cardiac Rhythm Management Devices Market
6.5. Italy Cardiac Rhythm Management Devices Market
6.6. Rest of Europe Cardiac Rhythm Management Devices Market
Chapter 7. Competitive Intelligence
7.1. Key Company SWOT Analysis
7.1.1. Company 1
7.1.2. Company 2
7.1.3. Company 3
7.2. Top Market Strategies
7.3. Company Profiles
7.3.1. BIOTRONIK SE & Co. KG
7.3.1.1. Key Information
7.3.1.2. Overview
7.3.1.3. Financial (Subject to Data Availability)
7.3.1.4. Product Summary
7.3.1.5. Market Strategies
7.3.2. Schiller AG
7.3.3. Medtronic PLC
7.3.4. Koninklijke Philips N.V.
7.3.5. Company 5
7.3.6. Company 6
7.3.7. Company 7
7.3.8. Company 8
7.3.9. Company 9
7.3.10. Company 10
Chapter 8. Research Process
8.1. Research Process
8.1.1. Data Mining
8.1.2. Analysis
8.1.3. Market Estimation
8.1.4. Validation
8.1.5. Publishing
8.2. Research Attributes